ArticleJCO precision oncology2024

Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma.

Miles C Andrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.